Get the Stockscreener App
0.00
100.00%
-7.62
After Hours:
1.08
1.08
+
Nls Pharmaceutics Ltd stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
See More
Previous Close:
$7.62
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$3.97M
Revenue:
-
Net Income/Loss:
$-15.47M
P/E Ratio:
0.00
EPS:
-0.5
Net Cash Flow:
$-13.51M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$30.80
Nls Pharmaceutics Ltd Stock (NLSP) Company Profile
Compare NLSP vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NLSP
Nls Pharmaceutics Ltd
|
0.00 | 3.97M | 0 | -15.47M | -13.51M | -0.50 |
VRTX
Vertex Pharmaceuticals Inc
|
433.07 | 110.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
737.71 | 77.99B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
691.40 | 42.91B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
317.36 | 42.09B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
283.03 | 31.42B | 5.36B | 287.73M | 924.18M | 2.5229 |
Nls Pharmaceutics Ltd Stock (NLSP) Latest News
If You Invested $1,000 in Nls Pharmaceutics Ltd (NLSP) - Stock Titan
Latest NLSPW NewsNLS Pharmaceutics to Participate in the Be... - Stock Titan
NLS Pharmaceutics Ltd. (NASDAQ:NCEL) Short Interest Update - Defense World
Market Catalysts: What is the next catalyst for ITRMStop Loss & Expert Approved Trade Ideas - baoquankhu1.vn
NLSP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Is NLS Pharmaceutics AG Equity Warrant forming a bullish divergenceJuly 2025 Movers & Low Risk High Win Rate Stock Picks - mfd.ru
Rate Cut: Is NLS Pharmaceutics AG stock a hidden gemJuly 2025 Fed Impact & Consistent Growth Equity Picks - baoquankhu1.vn
Bank Watch: Is BAYA forming a breakout patternJuly 2025 Action & Fast Entry High Yield Tips - baoquankhu1.vn
Value Recap: Why is Kforce Inc stock going down2025 Risk Factors & Weekly High Return Forecasts - baoquankhu1.vn
Earnings Update: Will NLS Pharmaceutics AG Equity Warrant benefit from geopolitical trendsWeekly Earnings Recap & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
NLS Pharmaceutics and Kadimastem Announce Completion of Material - GuruFocus
NLS Pharmaceutics Announces Reverse Share Split and Name Change Amid Merger - MSN
Published on: 2026-01-09 00:32:03 - ulpravda.ru
What valuation multiples suggest for NLS Pharmaceutics AG stock2025 Stock Rankings & Weekly Chart Analysis and Trade Guides - Улправда
Can NLS Pharmaceutics AG stock reach $100 price targetPortfolio Update Summary & AI Powered Buy and Sell Recommendations - Bollywood Helpline
Can NLS Pharmaceutics AG stock hit record highs again2025 Top Gainers & Safe Entry Trade Signal Reports - Улправда
What dividend safety score for NLS Pharmaceutics AG Equity Warrant stockMarket Growth Report & AI Forecasted Entry and Exit Points - Улправда
Is NLS Pharmaceutics AG stock a contrarian buyMarket Growth Review & Weekly Breakout Watchlists - Улправда
Is NLS Pharmaceutics AG Equity Warrant stock positioned well for digital economyQuarterly Risk Review & Daily Oversold Bounce Ideas - Newser
NLSP SEC FilingsNls Pharmaceutics Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025 - Aktiellt
Is NLS Pharmaceutics AG stock a top momentum playJuly 2025 Final Week & Risk Managed Investment Signals - Newser
NLS Pharmaceutics : to Present at the LD Micro Virtual Invitational Conference on June 10, 2021 - marketscreener.com
NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs (PR Newswire) - Aktiellt
NLS Pharmaceutics Highlights Continued Progress in iTOL-102 Diabetes Program as BIRD Foundation Approves Additional Milestone Payment to Kadimastem and iTolerance for Continued Co-Development of Type 1 Diabetes Cell Therapy (PR Newswire) - Aktiellt
NewCelX Appoints EY as New Auditor Following Merger - TipRanks
Will NLS Pharmaceutics AG stock gain from lower inflationWeekly Investment Report & AI Enhanced Trade Execution Alerts - newser.com
What institutional flow reveals about NLS Pharmaceutics AG Equity WarrantJuly 2025 Spike Watch & Growth Focused Stock Reports - newser.com
Is NLS Pharmaceutics AG stock attractive for passive investorsPortfolio Performance Report & Low Drawdown Momentum Trade Ideas - newser.com
Is NLS Pharmaceutics AG stock supported by innovation pipelineJuly 2025 Spike Watch & Growth Focused Investment Plans - newser.com
What candlestick patterns are forming on NLS Pharmaceutics AG2025 Pullback Review & Expert Curated Trade Ideas - newser.com
What to do if you’re stuck in NLS Pharmaceutics AG Equity WarrantStop Loss & Real-Time Volume Surge Alerts - newser.com
Will NLS Pharmaceutics AG Equity Warrant stock go up soonQuarterly Performance Summary & Risk Adjusted Swing Trade Ideas - newser.com
Can NLS Pharmaceutics AG stock attract ESG capital inflowsJuly 2025 EndofMonth & Fast Momentum Entry Tips - newser.com
Heatmap analysis for NLS Pharmaceutics AG Equity Warrant and competitors - newser.com
Is NLS Pharmaceutics AG Equity Warrant stock a bargain at current levelsMarket Activity Summary & Breakout Confirmation Trade Signals - newser.com
NewcelX appoints ALS specialist to scientific advisory board By Investing.com - Investing.com Nigeria
NewcelX appoints ALS specialist to scientific advisory board - Investing.com
NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute - Finviz
Is NLS Pharmaceutics AG Equity Warrant stock near bottom after declineGap Down & Community Driven Trade Alerts - newser.com
Real time scanner hits for NLS Pharmaceutics AG Equity Warrant explainedWeekly Trade Recap & Precise Buy Zone Identification - newser.com
Will NLS Pharmaceutics AG continue its uptrendTrade Volume Report & Growth Oriented Trade Recommendations - newser.com
Will NLS Pharmaceutics AG Equity Warrant continue its uptrendJuly 2025 Outlook & Stepwise Trade Signal Implementation - newser.com
What the charts say about NLS Pharmaceutics AG todayQuarterly Profit Summary & High Accuracy Investment Entry Signals - newser.com
Published on: 2025-11-12 22:54:02 - newser.com
Is NLS Pharmaceutics AG Equity Warrant stock a dividend growth opportunityTrade Exit Summary & Free Safe Entry Trade Signal Reports - newser.com
Analyzing NLS Pharmaceutics AG Equity Warrant with multi timeframe chartsJuly 2025 Opening Moves & Community Driven Trade Alerts - newser.com
Head to Head Contrast: NLS Pharmaceutics (NASDAQ:NCEL) vs. Addex Therapeutics (NASDAQ:ADXN) - Defense World
Nls Pharmaceutics Ltd Stock (NLSP) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.03%
2.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):